华体会和环球|华体会和环球

You have selected another country or region specific ELITechGroup website. 请注意,这个网站你有requested may contain local information for products meant for a specific market and possibly not approved in other countries. Do you wish to continue, exit this website and be led to your new choice? Yes No Customer Inquiry Form Member access Australia & New Zealand --> Elitech Group SAS × Global USA France Australia & New-Zealand Benelux Italy Latin America (Brazil) UK Menu Home About us About us History Distributors Worldwide Careers Products 188bet无法提款 ELITe InGenius Instrument ELITe InGenius Menu Open RT-PCR assays ELITechGroup Proprietary Technologies Clinical Chemistry Chemistry Systems Chemistry Reagents Osmometry Microbiology Instrumentation Obstetric and Pregnancy Bacteriology Mycology Parasitology Quality Controls Serology Virology Hematology Slide Stainers Cytocentrifuge Erythrocyte Sedimentation Rate Cell Image Analyzers Cystic Fibrosis Sweat Testing News Blog Events Press Releases Product News Support 188金宝搏app安卓下载 联系 联系 Subsidiaries Operations ELITechGroup offices MYCOFAST®Screening RevolutioN – Complement MYCOFAST®RevolutioN ATB+ (NEW!) --> Products Microbiology Bacteriology Mycoplasma Detection, enumeration, identification and complete antimicrobial susceptibility testing of urogenital mycoplasma: SCREENING METHOD NEW GENERATION:“Expanding the scope of treatment options!”- Extended panel of antibiotics tested (x11)! - 100% compliance with worldwide recommendations! Read more... The MYCOFAST®ScreeningRevolutioNkit and its Complement MYCOFAST®RevolutioN2 enable a complete diagnosis in 2 steps for urogenital mycoplasma diagnosis in various clinical specimens. It’s an accurate, cost-effective, easy-to-use colorimetric assay designed for the detection, enumeration, identification and antibiotic susceptibility determination ofUreaplasma urealyticum(U.u.) andMycoplasma hominis(M.h.) from urogenital specimens. The MYCOFAST®Screening approach provides the same results than with the direct method (MYCOFAST®RevolutioN2) but in an additional 24/48 hours. It can be chosen for economic reasons sometimes, or to reduce operation time on negative specimens. (MYCOFAST筛选步骤®ScreeningRevolutioN) allows the detection and differentiation of U.u. and M.h. after 24/48 hours of incubation. In case of a positive result, the second step (Complement MYCOFAST®RevolutioNATB+) will provide further information. Extended panel of antibiotics tested, in full compliance with worldwide recommendations Complete diagnosis in a two-phase approach Cost-effective screening in 24 hours The right pathologic threshold tested for each specimen type Visual, colorimetric reading Featuring ready-to-use reagents and an “all liquid” method, MYCOFAST®ScreeningRevolutioNand its Complement MYCOFAST®RevolutioNATB+offer a complete diagnosis of U.u. and M.h. in a flexible 2-steps approach. Moreover, the kit enables enumeration of U.u. > 103CCU/mL which is compliant with pathological thresholds recognized for sperm and urine samples. Finally, the UMMtRevolutioN传输介质使优化样品管理nt by preserving specimen integrity up to 72 hours. Read less... Request a quote Catalogue number(s) Reference Name Quantity 00061 UMMTRevolutioN 50 vials (Transport and inoculation medium) 00063 MYCOFAST®ScreeningRevolutioN 50 tests (10 trays of 5 x 2 wells) (Detection and differentiation of U.u/M.h) 00073 COMPLEMENT MYCOFAST®ScreeningRevolutioNATB+ 25 tests (25 trays) (Enumeration/ID/AST) 00064 Mycoplasma stabilizer 2 x 5 mL (2 x 50 specimens) Request a quote Already own this product? With the product code you gain access to the technical documents of this product. Instructions for use Features Specifications Related Products Mycoplasmas are the smallest and simplest of the procaryotypes capable of self-reproduction (0.15 to 0.25 μm). They differ from other bacteria in their lack of a cell wall and hence a natural resistance to ß-lactams. Since mycoplasmas are relatively fragile, they will only grow in acellular cultures in the presence of various growth factors and at a constant temperature of 35 to 37 °C. Most human mycoplasmas are commensal. Of the 9 species that have been isolated from the urogenital tract,Ureaplasma urealyticumandMycoplasma hominisare the most commonly found. U.u. and M.h. are sexually transmitted and can be pathogenic. Respiratory infections or meningitis can occur in the neonate as a result of contamination from the genital tract at birth. In adults, the infections caused by U.u. and M.h. are described in the table below: Conventional diagnosis is based upon culture on A7 agar plates followed by microscopical identification of U.u. (sea urchin shaped) or M.h. (fried-egg shaped) colonies. Since both U.u. and M.h. are commensal, infection can only be diagnosed through the determination of the pathological threshold, followed by precise enumeration. MYCOFAST®ScreeningRevolutioNand its COMPLEMENT MYCOFAST®RevolutioNATB+give the solution and make your urogenital diagnosis much easier. Principle MYCOFAST®ScreeningRevolutioNidentifies and differentiates U.u. from M.h. after incubating the clinical specimen in 2 wells containing 2 specific and separated growth media. During growth, U.u. and M.h. metabolize urea and arginine respectively resulting in a color change of the medium, which contains phenol red indicator, from yellow-orange to red. Mycoplasma growth thus viewed enables: Screening of U.u and M.h with the MYCOFAST®ScreeningRevolutioN. And in case of positivity, complete your diagnosis with the COMPLEMENT MYCOFAST®RevolutioNATB+: Enumeration of mycoplasma based on the rate of urea or arginine hydrolysis, which is proportional to the number of germs contained in the sample.U.u: > 103and 104CCU/mlM.h: > 104CCU/ml Identification secured by checking U.u/M.h natural resistance to 2 antibiotics (Clindamycin and Erythromycin) U.u and M.h susceptibility testing to 6 antibiotics compliant with worldwide recommendations:Levofloxacin (LVX) 1-2-4 μg/mL , Moxifloxacin (MXF) 0.25-0.5-2-4 μg/mL , Erythromycin (E) 8-16 μg/mL, Clindamycin (CM) 0.25-0.5 μg/mL Tetracyclin (TE) 1-2-4-8 μg/mL, and Telithromycin 4μg/mL U.u and M.h susceptibility testing to 5 other antibiotics: Minocycline (MIN) 2µg/ml, Ofloxacin (OFX) 1µg/ml, Josamycin (JOS) 2µg/ml, Pristinamycin (PRI) 2µg/ml and Roxithromycin (ROX) 1µg/ml Simple methodology *Reading of all samples in 24h. Second reading needed only for liquid samples having negative results within 24h. Easy-to-read and easy-to-interpret results The results are read by the color obtained in the different wells. Urogenital mycoplasma growth is indicated when the medium turnsred(alkaline). The medium remainsyellowwhen no growth of urogenital mycoplasma occurs. Reagents and material UMMtRevolutioN:Vial of 3 mL mycoplasma broth with antimicrobial agents and preservative solution. pH: 6.0 ± 0.1 25REF 00061UMMtRevolutioN– Quantity: 50 MYCOFAST®ScreeningRevolutioN:Divisible tray for 10 wells for 5 tests, individually packed in an aluminium sachet with an integrated desiccantREF 00063MYCOFAST®ScreeningRevolutioN– Quantity: 10 Labels:Sheet of 5 divisible labels(REF 00063MYCOFAST®ScreeningRevolutioN– Quantity: 10) MYCOFAST®RevolutioNATB+:Tray of 24 wells packed in an aluminium sachet with an integrated desiccantREF 00073Complement MYCOFAST®RevolutioNATB+– Quantity: 25 Closing system:Protective translucent plastic tray lid(REF 00073Complement MYCOFAST®RevolutioNATB+– Quantity: 25) Material required but not provided Sample collecting material (Swabs, cytobrushes, sterile containers for liquid samples) MYCOPLASMA STABILIZER (REF. 00064) Pipettes and tips Waste container for contaminated waste Mineral oil Incubator at 37 ± 1 °C Stability and storage All the reagents are ready-to-use. The vials may be stored at 2-8 °C, in their original packaging until the expiry date shown on the kit. Should only one or two, three, or four rows of (U.u) (M.h) wells be used, the remaining MYCOFAST®ScreeningRevolutioNtray may be stored for 4 weeks at 2-8 °C in its original packaging and hermetically resealed. The UMMt medium may be stored temporarily at room temperature but is more stable at2-8 °C. Do not freeze the reagents contained in the kit. MYCOFAST®RevolutioN ATB+ (NEW!) Detection, enumeration, identification and complete antimicrobial susceptibility testing of urogenital mycoplasma: DIRECT METHOD MYCOFAST®RevolutioN 2 (NEW!) Detection, enumeration, identification and complete antimicrobial susceptibility testing of urogenital mycoplasma: DIRECT METHOD NEW GENERATION: “Fulfilling your needs in the most demanding situations” – Compatible with Liquid-Amies collection/transport swabs ! – Optimized management of co-infection situations ! MYCOFAST®Screening RevolutioN – Complement MYCOFAST®RevolutioN 2 (NEW!) Detection, enumeration, identification and complete antimicrobial susceptibility testing of urogenital mycoplasma: SCREENING METHOD NEW GENERATION: “Fulfilling your needs in the most demanding situations” – Compatible with Liquid-Amies collection/transport swabs ! – Optimized management of co-infection situations ! Mycoplasma Control 为特征的菌株for the Quality Control of urogenital mycoplasma diagnosis. A7 Agar Agar plates for specific culture, enumeration and morphological identification of urogenital mycoplasma. Serology MUG Complementary immunological test to the direct detection of urogenital mycoplasma. UMMt RevolutioN / UMMt AMIES RevolutioN Optimized Transport Medium preserving specimen integrity for up to 72h before analysis How can we help you? For general inquiries please fill out the form on the right – for questions about specific products or pricing on products fill out the form on that product page. Someone will be in touch with you soon. --- Request typeGeneral inquiryProduct informationServiceQuoteRequest to be contacted by our local representative ProfileLaboratoryHospital laboratorySupplierPress / MediaOther May we send you emails in the future?*By clicking yes you sign up to our newsletter. YesNo By using this form you agree with the storage and handling of your data by this website. Company About us Support 联系 Careers News 金宝博软件 Privacy Policy Terms of use Facebook Twitter LinkedIn YouTube Menu This site uses functional COOKIEs and external scripts to improve your experience. My settings Accept Privacy Settings Required COOKIEs Functional COOKIEs Privacy Settings This site uses functional COOKIEs and external scripts to improve your experience. Which COOKIEs and scripts are used is specified on the left. You may change your settings at any time. Your choices will not impact your visit. NOTE:These settings will only apply to the browser and device you are currently using. Required COOKIEs These COOKIEs are required to enable core site functionality and are automatically enabled when you use this site. Functional COOKIEs These COOKIEs enable additional functionality like saving preferences and analyzing usage for site optimization. Enable Save my settings ✕